wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41670949-FBEB938A-B2DE-47D4-877B-58839E4571DB
Q41670949-FBEB938A-B2DE-47D4-877B-58839E4571DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41670949-FBEB938A-B2DE-47D4-877B-58839E4571DB
Integrins as Therapeutic Targets: Successes and Cancers.
P2860
Q41670949-FBEB938A-B2DE-47D4-877B-58839E4571DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41670949-FBEB938A-B2DE-47D4-877B-58839E4571DB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0266b0f1a7343425d62edcb4a027c1c3c4d48135
P2860
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.